AR company ThirdEye inks $100 million-plus contract with biotechnology company OmGeneum

(Nweon October 18, 2023) ThirdEye, an MR end-to-end solution provider, recently announced the signing of a multi-year contract worth more than US$100 million with OmGeneum, a Japanese regenerative bioengineering company. The two parties will work to integrate ThirdEye's AI-driven smart glasses, customized AI/MR software applications, and OmGeneum's technology platform to fundamentally optimize the medical industry. Rewritten content: ThirdEye and OmGeneum have signed a multi-year contract worth more than $100 million to combine AI-powered smart glasses, custom AI/MR software applications and OmGeneum’s technology platform to fundamentally optimize the medical industry

OmGeneum is developing next-generation technologies designed to modulate the regeneration of target tissues, organs or cells to improve the effectiveness of regenerative (stem cell) drug treatments for neurological diseases, disorders and dysfunction

As part of the contract, ThirdEye will work with OmGeneum to provide ThirdEye’s AI-powered smart glasses and AI/MR software for a variety of medical applications, including vision impairment, Alzheimer’s disease, remote surgery, surgery 3D overlay, health AI analysis, first responder assistance, etc.

Among them, the AI system can superimpose key data on the staff's field of vision, thereby significantly improving work efficiency. In addition, AI can provide critical data analysis insights to assist medical and drug research and development

OmGeneum said: “We are excited about our long-term collaboration in artificial intelligence, mixed reality and healthcare. ThirdEye’s technology has been validated by the highest levels of the U.S. military and their technology is aligned with our industry-leading capabilities in the health vertical. The combination of expertise will provide innovative technological approaches that can help save millions of lives and enable advanced healthcare applications. Japan currently has the highest proportion of elderly people and the largest number of centenarians in the world, and holographic technology can provide Important help."

ThirdEye said: "ThirdEye was founded with the mission to fundamentally change the way we live and solve today's major medical problems through AI/MR solutions. We will continue to support our customers around the world and be confident that our technology will be used in hundreds of Excited about new deployments at medical facilities and schools."

The above is the detailed content of AR company ThirdEye inks $100 million-plus contract with biotechnology company OmGeneum. For more information, please follow other related articles on the PHP Chinese website!